Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
September 9, 2016, Law360
Wade Ackerman and Denise Esposito are quoted in a Law360 article regarding Ackerman’s recent arrival as a partner in the firm’s Food, Drug, and Device practice. According to Ackerman, he’d like to serve as bridge between Washington, D.C., and Los Angeles for the firm. For a food and drug attorney, Covington is the place to go, given its “long history of having a top practice.”
“It’s a period of unprecedented change that’s going on right now in the medical product space,” Ackerman says. “We’re seeing precision medicine really be realized in a way that wasn’t around even a few years ago. We’re also in a period of unprecedented change in the ways technology is integrating into diagnostics and to health care delivery. Frankly, the center of that kind of medical innovation is the West Coast.”
Esposito notes, “Wade’s depth of substantive life sciences expertise, high profile in the industry, and government experience with FDA issues, in both the legislative and executive branches, position him as a leading food, drug, and device lawyer.” She continues, “We anticipate that his experience working on FDA-related reforms, both from within the FDA and on the Hill, will make his counsel highly sought after by companies around the world.”